TB

This document is intended to raise awareness about TB/HIV research priorities (i.e. areas that require urgent funding and scientific interest), help coordinate advocacy efforts, and encourage research funding. The aim is to increase the implementation of high-quality, integrated TB/HIV interventions in resource-limited settings. The document outlines a revised research priority agenda based on the latest evidence in six key areas of TB and HIV co-infection.

The purpose of this document is to highlight cases in which Advocacy, Communication and Social Mobilization (ACSM) interventions have contributed to a positive outcome of tuberculosis (TB) control activities directed to a range of audiences and settings. It is intended for on-the-ground stakeholders who are interested in successfully integrating ACSM strategies and activities into TB control programming, as well as for decision-makers who can provide greater political and financial support for ACSM activities at the national, sub-national and international level.

This document addresses a broad range of ethical issues arising in TB programmes, ranging from informed consent and isolation to health-care workers' rights and obligations, and clinical and epidemiological studies.

This guide aims to improve case detection, management, and outcomes of children with TB.

This December 2009 presentation aims to foster reflection on and a debate about the role of communication in addressing tuberculosis (TB). The authors propose a conceptual framework of communication and its relation to ethics, building from previous experience in order work against stigma and discrimination in health care contexts by developing the advocacy, communication, and social mobilisation (ACSM) model.

The case highlighted in this issue came from a state health department nurse who lived in the small town located on a large Great Plains Indian reservation where this case unfolded. It involved an extended family spanning 4 generations, all of whom lived in the same 3-bedroom house.

The challenges of TB-HIV co-Infection are highlighted in this issue. Psychosocial aspects of HIV diagnosis and self-awareness are also discussed.

This report highlights the issues surrounding high prices and poor supply of the drugs needed to treat drug-resistant tuberculosis (DR-TB). The report provides an overview of available drug-resistant TB medicines, including drug sources, quality status, and price.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.

The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.

This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.